Page Comparison

The Sjögren's Foundation Clinical Trials Consortium (CTC) was formed to facilitate international collaboration and increase the availability and accessibility of therapies for treating Sjögren's.

Goals of the CTC are to:

1. Support and promote objectives that facilitate the design of clinical trials
2. Increase industry partnerships with the Sjögren's Foundation
3. Engage in dialogue with government agencies that oversee therapy approval. (i.e. FDA, EMA) 

Sjögren’s Foundation Clinical Trials Consortium Steering Committee Members:

• Chair: Theresa Lawrence Ford, MD
  
  
• US -
• Alan Baer, MD
• Steve Carsons, MD
• Nancy Carteron, MD
• Robert Fox, MD, PhD
• Hal Scofield, MD
• Frederick Vivino, MD
• Daniel Wallace, MD
• Oral - Athena Papas, DMD, PhD
• Ocular -  Esen Akpek, MD

• FRANCE -
• Xavier Mariette, MD, PhD / Raphaèle Seror, MD, PhD
• Valerie Devauchelle Pensec, MD, PhD
• Jacques-Eric Gottenberg, MD, PhD
  
  
• GREECE -
• Athanasios Tzioufas, MD
  
  
• ITALY -
• Salvatore Devita, MD / Chiara Baldini, MD, PhD
• Claudio Vitali, MD
  
  
• NETHERLANDS -
• Hendrika Bootsma, MD, PhD
  
  
• SPAIN
  • Manuel Ramos-Casals, MD, PhD

• UK -
• Simon Bowman, PhD, MBBS / Ben Fisher, MD
• Wan-Fai Ng, PhD, MB BChir